Eagle Pharma Recalls Phenylephrine Infusion Due to Sterility Risk
Eagle Pharma recalls 50 containers of Phenylephrine HCL Infusion due to lack of sterility assurance. Check lot PHENYL100-1004.
Stop using this now
Lack of Assurance of Sterility
What happened, in plain English
Eagle Pharma Outsourcing LLC is recalling a specific lot of Phenylephrine HCL Infusion because there is no assurance that the product remains sterile. The recall affects 50 containers distributed nationwide within the U.S. This issue poses a potential infection risk to patients receiving this medication. Read more at govinfonow.com/recall/2084742-eagle-pharma-outsourcing-llc-recalls-phenylephrine-hcl-infusion-100-mg.
Source Summary by GovInfoNow · govinfonow.com/recall/2084742-eagle-pharma-outsourcing-llc-recalls-phenylephrine-hcl-infusion-100-mg · Updated November 11, 2026 · FDA enforcement record: FDA #D-0105-2027
Cite this page
“Eagle Pharma Recalls Phenylephrine Infusion Due to Sterility Risk.” GovInfoNow, updated November 11, 2026. https://govinfonow.com/recall/2084742-eagle-pharma-outsourcing-llc-recalls-phenylephrine-hcl-infusion-100-mg. Based on FDA recall #D-0105-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0105-2027%22&limit=1).
Why it’s dangerous
The product lacks assurance of sterility, meaning harmful microorganisms could be present in the solution. Using a non-sterile intravenous infusion can lead to serious infections or sepsis in patients.
Who’s affected
Healthcare providers and patients in the United States who received the specific lot of Phenylephrine HCL Infusion from Eagle Pharma Outsourcing LLC are affected. Patients relying on this sterile infusion for medical treatment are at risk of infection.
How to tell if you have this one
Check if you have Phenylephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use. Look for NDC 69852-100-25, Lot PHENYL100-1004, and Expiry date 12/31/2026. The UPC is 6985210025.
- Brand
Eagle Pharma- Product
PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide within the U.S
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0105-2027 | PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25; Lot: PHENYL100-1004, Expiry: 12/31/2026. | 50 250 mL-containers |
| D-0106-2027 | OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50; Lot: OXY30-1006, Expiry: 10/10/2026. | 5 500-mL containers |
What to do — step by step
Stop Using the Product
Do not administer or use any Phenylephrine HCL Infusion from the recalled lot due to sterility concerns.
Identify Affected Lots
Verify if your inventory matches Lot PHENYL100-1004, NDC 69852-100-25, and Expiry 12/31/2026.
Contact Manufacturer
Reach out to Eagle Pharma Outsourcing LLC for further instructions on handling the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 27 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0105-2027 (October 8, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0105-2027 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on November 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.